Who is this course for?
Clinicians, therapists, researchers, clergy, and professionals in licensed mental health, medical, and legal professions.
The Psychedelic-Assisted Therapies and Research Certificate Program at the California Institute for Integral Studies (CIIS) Center for Psychedelic Therapies and Research (CPTR) is designed to meet the growing need for the training of skilled therapists and researchers in the field of psychedelic-ass
CIIS
English
Next cohort: Jun 1, 2026
150 hours
Start date: June 1, 2026
Application deadline: June 1, 2026
The Psychedelic-Assisted Therapies and Research Certificate Program at the California Institute for Integral Studies (CIIS) Center for Psychedelic Therapies and Research (CPTR) is designed to meet the growing need for training skilled therapists and researchers in the field of psychedelic-assisted and entactogen-assisted psychotherapy research and clinical work. The program is open to professionals in licensed mental health, medical, and legal professions, as well as ordained or commissioned clergy and chaplains. The curriculum encompasses intellectual, personal, and applied learning, covering topics such as the pharmacology of psychoactive substances, research design, therapist and facilitator competencies, the global history of psychoactive plant use, and cultural competencies. The program emphasizes clinical work with MDMA and psilocybin, with additional coursework on ketamine-assisted psychotherapy. Led by Dr. Janis Phelps and a multidisciplinary team of international experts, the program integrates contemporary research with spiritual, cultural, and traditional wisdom practices. Trainees engage in a supportive learning community focused on ethical care, personal growth, and professional connection.
Clinicians, therapists, researchers, clergy, and professionals in licensed mental health, medical, and legal professions.
Open to professionals in licensed mental health, medical, and legal professions, as well as ordained or commissioned clergy and chaplains.
The California Institute of Integral Studies (CIIS) launched the world's first university-affiliated Psychedelic-Assisted Therapies and Research Certificate Program in 2015, establishing the gold standard for post-graduate psychedelic clinician training, with cohorts now also offered a B.S. in Psychedelic Studies and a KAP clinic. Based in San Francisco, CIIS is a non-profit graduate university pioneering integral approaches to consciousness, therapy, and psychedelic medicine.
Clinicians, therapists, researchers, clergy, and professionals in licensed mental health, medical, and legal professions.
Open to professionals in licensed mental health, medical, and legal professions, as well as ordained or commissioned clergy and chaplains.
Format: Hybrid. Time commitment: 150 hours.
The listed price is $8,300. Confirm the latest tuition, fees, and payment options with [object Object].
The listing includes a certificate signal. Accreditation note: CE. Confirm credential eligibility directly with the provider before enrolling.
The listed next cohort date is 2026-06-01. The listed application deadline is 2026-06-01.
The current listing status is Active. Use the provider website for the latest enrollment status.
By Fluence
Shares course skills and categories
A professional certificate program in psychedelic-assisted therapies and research offered by CIIS. It covers clinical and research foundations including pharmacology, research design, therapist competencies, and cultural and historical context.
Next cohort: Jun 1, 2026
By SCPTR
Shares course skills and categories
Salt City Psychedelic Therapy and Research (SCPTR) presents the Psychedelic Therapy Training Program, an all-encompassing 8-week course tailored for those who are keen to embark on a career as therapists and healers in the rapidly emerging domain of psychedelic therapy.
By SoundMind
Shares course skills and categories
SoundMind Psychedelic Facilitator Training is an 8-month certificate program for Oregon psilocybin facilitator training. It covers psychedelic-assisted therapy topics, including ketamine, psilocybin, and MDMA in therapeutic settings.
Next cohort: Sep 1, 2026
Delivery: Online + United States
Includes medicine self-experience